Neurogene Inc (NGNE) — Cash Flow-to-Debt Ratio
Neurogene Inc (NGNE) has a Cash Flow-to-Debt Ratio of -1.03x as of March 2026, meaning its operating cash flow of $-26.12 Million could theoretically repay -1% of its total liabilities ($25.36 Million) in one year. See NGNE financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Neurogene Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Neurogene Inc across 15 annual periods. For the full cash flow conversion analysis, see NGNE cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Neurogene Inc (2011–2025)
Year-by-year debt coverage analysis for Neurogene Inc. Check cash flow quality index of Neurogene Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.25x | $-77.17 Million | $23.72 Million | ▼ -16.9% |
| 2024 | -2.78x | $-70.60 Million | $25.36 Million | ▼ -97.9% |
| 2023 | -1.41x | $-51.42 Million | $36.55 Million | ▲ +71.7% |
| 2022 | -4.97x | $-52.82 Million | $10.64 Million | ▼ -1969.3% |
| 2021 | -0.24x | $-46.40 Million | $193.36 Million | ▲ +81.2% |
| 2020 | -1.27x | $-24.57 Million | $19.30 Million | ▲ +55.9% |
| 2019 | -2.88x | $-15.39 Million | $5.34 Million | ▲ +54.8% |
| 2018 | -6.38x | $-31.58 Million | $4.95 Million | ▼ -63.4% |
| 2017 | -3.91x | $-44.72 Million | $11.44 Million | ▼ -25.6% |
| 2016 | -3.11x | $-30.23 Million | $9.72 Million | ▲ +24.4% |
| 2015 | -4.12x | $-20.27 Million | $4.92 Million | ▼ -22.0% |
| 2014 | -3.38x | $-17.81 Million | $5.28 Million | ▼ -218.2% |
| 2013 | -1.06x | $-7.94 Million | $7.48 Million | ▲ +78.5% |
| 2012 | -4.93x | $-7.23 Million | $1.47 Million | ▲ +34.8% |
| 2011 | -7.55x | $-9.80 Million | $1.30 Million | — |